Blue biotechnology: Increase Demand of Marine Products Favors the Growth of this Market

Pune, India, March 26, 2022/press release/- Market Research Future Published a Half Cooked Research Report on Global Blue biotechnology Research Report.

Market Highlights

The Blue biotechnology Market is expected to reach USD 1.3 Billion at 14.30% CAGR during the forecast period 2023-2032

Blue biotechnology provides numerous advantages like use of marine organisms in the field of biotechnology by modifying their genome, and diagnosis of diseases through microbial testing which contributes to the growth of this market. Application of marine biotechnology in the field of clinical diagnosis is found to be increasing from last few years. Drug discovery is one of the most promising outcomes of marine biotechnology research due to the use of bio chemicals produced by marine organisms such as algae, bacteria and other invertebrates, for manufacturing new classes of medicines. Increasing demand of marine biotechnology products, increasing application of marine biotechnology in healthcare and extensive research and development activities drives the growth of this market globally. 

Test the market data and market information presented through more than 45 market data tables and figures spread over 80 pages of the project report. Avail the in-depth table of content TOC & market synopsis on “Blue Biotechnology Market Research Report –Global Forecast to 2032.”

Global Blue Biotechnology Market Players

Among numerous players, key players of this market as recognized by Market Research Future  are Aker BioMarine (Norway), Marinova (Australia), New England Biolabs (U.S), PML Applications Ltd. (U.K), Sea Run Holdings, Inc.(U.S), PICES (Canada), Donald Danforth Plant Science Center (U.S), Shell Marine Products (U.S), GeoMarine Biotechnologies (India),  GlycoMar (Scotland), Cellgen Biologicals Pvt Ltd. (India), Nurture Aqua Technology Pvt. Ltd. (India), Samudra Biopharma Pvt.Ltd (India) and Sanosil Biotech (India)

Aker BioMarine is a Norwegian fishing and biotech company.  It received the award for "strategically investing more than USD 550 million to build out the krill supply chain in the Antarctic.

Marinova is an Australian biotechnology company, involved in the production of high purity seaweed extracts.

Segmentation

Global blue biotechnology market has been segmented on the basis of products which includes enzymes, pharma products, bulk chemicals, biopolymers and others. On the basis of application, the market is segmented into bio-engineering, genomics, vaccine development, drug discovery and others. On the basis of end users, the market is segmented into hospitals, pharmaceutical companies, biotechnology companies, research institutes, laboratories, and others.

Regional Analysis

Globally, blue biotechnology market consists of four regions namely Americas, Europe, Asia-Pacific and Middle East & Africa. America is the largest market due to an increase in demand of blue biotechnology products, awareness regarding applications of blue biotechnology in vaccine development and presence of large number of biotechnology companies engaged in research and development activities in blue biotechnology. Europe is the second largest market owing to an increase in the demand of marine biotechnology products. Asia Pacific shows a steady growth of this market as blue biotechnology is not much applied in various fields. In Middle East & Africa, this market shows a slow growth.

Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Blue biotechnology Market Research Report